Skip to main content

Table 5 Model 2: Patient values vs. those of ethnic minorities (96 out of 908 are ethnic minorities)

From: Who should be prioritized for renal transplantation?: Analysis of key stakeholder preferences using discrete choice experiments

Variable Coefficient for non-ethnic minorities MRS for non-ethnic minorities Coefficient for dummy variables for ethnic minorities MRS for ethnic minority patients Wald test p-values
Wait .0451* 1 -.0061 1  
Tiss .0698* 1.54* -.0630** 0.17 p<0.0001
   (1.19 / 1.90)   (−0.82 / 1.17)  
Dep .0595* 1.32* .0351* 2.42* p=0.2755
   (1.05 / 1.59)   (1.40 / 3.44)  
Age .0071* 0.16* -.0011 0.15* p=0.0024
   (0.12 / 0.20)   (0.03 / 0.27)  
dis1 .0039 0.09 -.0398 −0.92 p=0.6014
   (−0.98 / 1.15)   (−4.41 / 2.57)  
dis2 .7158* 15.86* -.3153** 10.25* p<0.0001
   (13.87 / 17.85)   (4.96 / 15.53)  
ill1 -.1085* −2.40* -.0903 −5.08* p=0.9050
   (−1.06 / -3.74)   (−0.83 / -9.33)  
ill2 .1773* 3.93* .0647 6.19* p=0.2558
   (2.82 / 5.03)   (2.51 / 9.88)  
Intercepts .1269*   -.0510   
Variable Non-ethnic minorities trade-off between variable & 1 year wait Non-ethnic minorities trade-off between variable & 5 year wait Ethnic minority trade-off between variable & 1 year wait Ethnic minority trade-off between variable & 5 year wait  
Prioritizing perfect not favourable tissue matches 1.54* 0.31* 0.17 0.35  
  (1.19 / 1.90) (0.24 / 0.38) (−0.82 / 1.17) (−0.16/ 0.23)  
Prioritizing favourable not non- favourable tissue matches. 4.64* 0.93* 0.52 0.10  
  (3.57 / 5.70) (0.71 / 1.14) (−2.46 / 3.50) (−0.49 / 0.70)  
Prioritizing a recipient with dependents per extra dependent 1.32* 0.26* 2.42** 0.48*  
  (1.05 / 1.59) (0.21 / 0.32) (1.40 / 3.44) (0.28 / 0.69)  
prioritizing a younger recipient per year younger 0.16* 0.03* 0.15* 0.03*  
  (0.12 / 0.20) (0.02 / 0.04) (0.03 / 0.27) (0.01 / 0.05)  
Prioritizing those with no not moderate diseases affecting life expectancy 0.09 0.02 −0.92 −0.18  
  (−0.98 / 1.15) (−0.20 / 0.23) (−4.41 / 2.57) (−0.88 / 0.51)  
Prioritizing those with moderate not severe diseases affecting life expectancy 15.86* 3.17* 10.25* 2.05*  
  (13.87 / 17.85) (2.77 / 3.57) (4.96 / 15.53) (0.99 / 3.11)  
Prioritizing those with no not moderate diseases affecting QoL −2.40* −0.48* −5.08* −1.02*  
  (−1.06 / -3.74) (−0.21 / -0.75) (−0.83 / -9.33) (−0.17 / -1.87)  
Prioritizing those with moderate not severe diseases affecting QoL 3.93* 0.79* 6.19* 1.24*  
  (2.82 / 5.03) (0.56 / 1.01) (2.51 / 9.88) (0.50 / 1.98)  
  1. *: Significant at the 5% level; Figures in parentheses indicate 95% confidence intervals for point estimates.
  2. Includes MRS expressed in terms of utility value of other attributes expressed in terms of trade-off with 1 year and 5 year waiting time.